statistiche ricercatore

Continente	#
AS - Asia	662
EU - Europa	522
NA - Nord America	447
SA - Sud America	75
AF - Africa	33
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.742

Nazione	#
US - Stati Uniti d'America	432
IT - Italia	248
SG - Singapore	203
CN - Cina	184
HK - Hong Kong	84
BR - Brasile	64
GB - Regno Unito	59
BD - Bangladesh	58
DE - Germania	44
IN - India	35
RU - Federazione Russa	33
NL - Olanda	31
VN - Vietnam	31
FI - Finlandia	28
FR - Francia	22
ZA - Sudafrica	14
KR - Corea	13
JP - Giappone	12
SE - Svezia	10
ID - Indonesia	9
PK - Pakistan	9
CA - Canada	8
EG - Egitto	8
SK - Slovacchia (Repubblica Slovacca)	7
DK - Danimarca	6
CZ - Repubblica Ceca	5
IE - Irlanda	5
MX - Messico	5
AR - Argentina	4
AT - Austria	4
IL - Israele	4
IR - Iran	4
TW - Taiwan	4
BE - Belgio	3
BY - Bielorussia	3
CH - Svizzera	3
CI - Costa d'Avorio	3
GH - Ghana	3
PL - Polonia	3
PT - Portogallo	3
AZ - Azerbaigian	2
EC - Ecuador	2
ES - Italia	2
GR - Grecia	2
SA - Arabia Saudita	2
TN - Tunisia	2
TR - Turchia	2
AU - Australia	1
BH - Bahrain	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
IQ - Iraq	1
MA - Marocco	1
MY - Malesia	1
NG - Nigeria	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
SN - Senegal	1
TH - Thailandia	1
TJ - Tagikistan	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
VE - Venezuela	1
Totale	1.742

Nome	#
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus	254
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy	201
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis	193
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria	192
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients	178
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB	172
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation	168
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids	162
Repurposing of FDA‐Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach	135
5-(4-Nitrophenyl)furan-2-carboxylic Acid	118
Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives	9
Discovery of Potent Benzoselenazinone-Based DprE1 Inhibitors: A Novel Selenium-Containing Scaffold with Superior Anti-TB Activity and Pharmacokinetic Properties	9
Totale	1.791

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	21	0	0	0	0	0	6	12	0	1	0	1	1
2023/2024	152	0	1	2	0	4	0	50	15	12	22	26	20
2024/2025	539	22	39	32	23	37	25	27	38	43	73	73	107
2025/2026	1.079	100	141	124	148	80	54	147	31	68	61	125	0
Totale													1.791

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca